Minerva Neurosciences, Inc. (NERV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 15M 30M 45M Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 41.2M Q3 '20: 41.2M Q4 '20: 41.2M Q1 '21: 41.2M Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q4 '18 Q2 '19 Q4 '19 Q2 '20 Q4 '20 Q2 '21 Q4 '21

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '16: -29.1M Q4 '16: -30.2M Q1 '17: -32.9M Q2 '17: -37.7M Q3 '17: -40.9M Q4 '17: -41.2M Q1 '18: -43.4M Q2 '18: -46.6M Q3 '18: -47.6M Q4 '18: -51.7M Q1 '19: -55.3M Q2 '19: -55.3M Q3 '19: -57.1M Q4 '19: -75.9M Q1 '20: -71.8M Q2 '20: -29.4M Q3 '20: -23.2M Q4 '20: 1.8M Q1 '21: 6.6M Q2 '21: -31.9M Q3 '21: -31.3M Q4 '21: -45.4M Q1 '22: -45.8M Q2 '22: -43.8M Q3 '22: -41.5M Q4 '22: -25.2M Q1 '23: -22.6M Q2 '23: -20.1M Q3 '23: -21M Q4 '23: -23.1M Q1 '24: -24.5M Q2 '24: -26.2M Q3 '24: -24.5M Q4 '24: -21.8M Q1 '25: -19.1M Q2 '25: -16.2M Q3 '25: -14.6M Q4 '25: -15.1M Q1 '26: -27.9M Q2 '26: -35.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-450M -300M -150M 0 150M 300M 450M Q3 '16: -30.1M Q4 '16: -31M Q1 '17: -33.7M Q2 '17: -38.3M Q3 '17: -41.1M Q4 '17: -31.5M Q1 '18: -33.3M Q2 '18: -36M Q3 '18: -36.8M Q4 '18: -50.2M Q1 '19: -53.6M Q2 '19: -53.5M Q3 '19: -55.5M Q4 '19: -72.2M Q1 '20: -68.5M Q2 '20: -26.5M Q3 '20: -20.7M Q4 '20: 1.9M Q1 '21: 5.3M Q2 '21: -34.8M Q3 '21: -35.9M Q4 '21: -49.9M Q1 '22: -50.9M Q2 '22: -49M Q3 '22: -46.7M Q4 '22: -32.1M Q1 '23: -29.3M Q2 '23: -26.8M Q3 '23: -27.7M Q4 '23: -30M Q1 '24: -31.6M Q2 '24: -33.6M Q3 '24: -3.3M Q4 '24: 1.4M Q1 '25: 6.3M Q2 '25: 11.2M Q3 '25: -14M Q4 '25: -293.4M Q1 '26: -415.1M Q2 '26: -394.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q3 '16: -23.4M Q4 '16: -25.7M Q1 '17: -25.7M Q2 '17: -26.5M Q3 '17: 3.1M Q4 '17: 3.1M Q1 '18: -1.8M Q2 '18: -6.2M Q3 '18: -41.1M Q4 '18: -41.9M Q1 '19: -40.6M Q2 '19: -39.5M Q3 '19: -39.1M Q4 '19: -43.4M Q1 '20: -43M Q2 '20: -40.5M Q3 '20: -40.8M Q4 '20: -33.8M Q1 '21: -29.8M Q2 '21: -28.2M Q3 '21: -26.9M Q4 '21: -24.6M Q1 '22: -25.2M Q2 '22: -24.5M Q3 '22: -25.4M Q4 '22: -24.6M Q1 '23: -19M Q2 '23: -17.6M Q3 '23: -12.9M Q4 '23: -14.8M Q1 '24: -20.8M Q2 '24: -20.8M Q3 '24: -20.4M Q4 '24: -19.6M Q1 '25: -17.5M Q2 '25: -15.6M Q3 '25: -14.2M Q4 '25: -13.5M Q1 '26: -14.9M Q2 '26: -26.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 30M 60M 90M Q2 '19: 39M Q3 '19: 39M Q2 '20: 40.3M Q3 '20: 41.9M Q2 '21: 42.7M Q3 '21: 5.3M Q1 '22: 5.3M Q2 '22: 5.3M Q3 '22: 5.3M Q1 '23: 5.3M Q2 '23: 5.5M Q3 '23: 7.6M Q1 '24: 7.6M Q2 '24: 7.6M Q3 '24: 7.6M Q1 '25: 7.6M Q2 '25: 7.6M Q3 '25: 7.6M Q1 '26: 43.9M Q2 '26: 79.1M Q3 '19 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-45.00 -30.00 -15.00 0.00 15.00 30.00 45.00 Q3 '16: -1.06 Q4 '16: -0.99 Q1 '17: -1.00 Q2 '17: -1.09 Q3 '17: -1.13 Q4 '17: -0.84 Q1 '18: -0.86 Q2 '18: -0.91 Q3 '18: -0.94 Q4 '18: -1.29 Q1 '19: -1.38 Q2 '19: -1.38 Q3 '19: -1.43 Q4 '19: -1.86 Q1 '20: -1.76 Q2 '20: -0.71 Q3 '20: -0.54 Q4 '20: 0.05 Q1 '21: 0.15 Q2 '21: -0.83 Q3 '21: -2.36 Q4 '21: -6.17 Q1 '22: -7.79 Q2 '22: -9.17 Q3 '22: -8.74 Q4 '22: -6.01 Q1 '23: -5.49 Q2 '23: -4.98 Q3 '23: -4.72 Q4 '23: -4.66 Q1 '24: -4.48 Q2 '24: -4.45 Q3 '24: -0.45 Q4 '24: 0.19 Q1 '25: 0.82 Q2 '25: 1.48 Q3 '25: -1.85 Q4 '25: -34.67 Q1 '26: -37.03 Q2 '26: -36.74 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.